Northwest Biotherapeutics sells 8.125M shares at $0.40 to SIO Capital for $3.25M

NORTHWEST BIOTHERAPEUTICS INC

SPA signed June 4, 2024; closing expected June 5, 2024.
Gross proceeds of $3,250,000 from sale of 8,125,000 shares of common stock.
Proceeds to be used for ongoing business operations.
SIO Capital Management LLC is the purchaser; Joseph Gunnar & Co. acted as placement agent.

item 1.01

NORTHWEST BIOTHERAPEUTICS INC filing history →

Source: SEC EDGAR

accession 0001104659-24-068314

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.